Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > AI Enhances Outreach to Blood Donors
While collecting blood, Versiti collects data. Versiti is a nonprofit founded in 1947 with the two goals of providing a sustainable blood s...
No comments:
Post a Comment